Your browser doesn't support javascript.
loading
A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
Garcia, Christine; Yao, Aaron; Camacho, Fabian; Balkrishnan, Rajesh; Cantrell, Leigh A.
Afiliação
  • Garcia C; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia, Charlottesville, VA, United States. Electronic address: cg5zc@virginia.edu.
  • Yao A; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United States.
  • Camacho F; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United States.
  • Balkrishnan R; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, United States.
  • Cantrell LA; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Virginia, Charlottesville, VA, United States.
Gynecol Oncol ; 146(2): 346-350, 2017 08.
Article em En | MEDLINE | ID: mdl-28499649

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Sistema de Registros / Neoplasias Císticas, Mucinosas e Serosas / Neoplasias Epiteliais e Glandulares / Hipoglicemiantes / Metformina Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Sistema de Registros / Neoplasias Císticas, Mucinosas e Serosas / Neoplasias Epiteliais e Glandulares / Hipoglicemiantes / Metformina Idioma: En Ano de publicação: 2017 Tipo de documento: Article